“Evidence-Based Prioritization and Scoring of Genomic Loci Interacting With Pioglitazone Therapeutic Response in Diabetic Patients”. 2022. Precision Medicine Communications 2 (2): 91-108. https://doi.org/10.55627/pmc.002.02.0188.